The 21 European Biotech Companies to Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much…
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
Try as we might, we can’t cover every bit of news out there. So relax…
New approaches to tame the immune system in the fight against cancer are getting us…
How has CRISPR changed drug development? How do you negotiate a good partnership? What are…
The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR…
The biotech industry has often been criticized for its lack of gender diversity. While there…
The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for…
Abingworth has closed $315M (€268M) for its most recent fund, Abingworth Bioventures VII, which invests in…